InMed Pharms Stock Price, News & Analysis

IMLFF OTC

Company Description

InMed Pharms (OTC: IMLFF) is a publicly traded biotechnology company in the Health Technology sector.

This page provides a comprehensive overview of IMLFF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

5.2M

Shares outstanding

Latest News

View All

February 16, 2021

—

InMed Announces Closing of US$4.5 Million Private Placement

private placement

February 11, 2021

—

InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results

earnings

February 6, 2021

—

InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results

conferences earnings

February 5, 2021

—

InMed Announces US$4.5 Million Private Placement

private placement

InMed Pharms has 4 recent news articles. Key topics include private placement, earnings, conferences. View all IMLFF news →

SEC Filings

View All

No SEC filings available for IMLFF.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

IMLFF Company Profile & Sector Positioning

InMed Pharms (IMLFF) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the OTC.